Evidence map›Paper›PMID 36399640›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Cost-Effective H

Xu Chen, Ziqi Tian, Qihao Yang, Linjuan Zhang, Qiu Yang, Liang Chen, Zhiyi Lu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Cost-Effective HAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xu ChenKey Laboratory of Advanced Fuel Cells and Electrolyzers Technology of Zhejiang Province, Qianwan Institute of CNITECH, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, Zhejiang, 315201, P. R. China.ORCID https://orcid.org/0000-0002-9870-7287
Ziqi TianKey Laboratory of Advanced Fuel Cells and Electrolyzers Technology of Zhejiang Province, Qianwan Institute of CNITECH, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, Zhejiang, 315201, P. R. China.
Qihao YangKey Laboratory of Advanced Fuel Cells and Electrolyzers Technology of Zhejiang Province, Qianwan Institute of CNITECH, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, Zhejiang, 315201, P. R. China.
Linjuan ZhangKey Laboratory of Advanced Fuel Cells and Electrolyzers Technology of Zhejiang Province, Qianwan Institute of CNITECH, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, Zhejiang, 315201, P. R. China.
Qiu YangNingbo New Material Testing and Evaluation Center Co., Ltd, Ningbo New Materials Innovation Center, Ningbo, Zhejiang, 315201, P. R. China.
Liang ChenUniversity of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
Zhiyi LuKey Laboratory of Advanced Fuel Cells and Electrolyzers Technology of Zhejiang Province, Qianwan Institute of CNITECH, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, Zhejiang, 315201, P. R. China.ORCID https://orcid.org/0000-0002-2117-4101

Funding

Hundred Talents Programs in the Chinese Academy of ScienceNational Natural Science Foundation of China 52201285Ningbo S&T Innovation 2025 Major Special Program 2020Z059Ningbo S&T Innovation 2025 Major Special Program 2020Z103Ningbo Yongjiang Talent Introduction Programme 2021A-036-B
6 · The paper itself

Abstract

The reuse of powdered activated carbon (PAC) vitally determines the economics and security of the PAC-based adsorption process, while state-of-the-art PAC regeneration technologies are usually unsatisfactory. Here, it is demonstrated that isolated Fe sites anchored on commercial PAC enable fast H

Indexed as

Fe-based reactive oxygen species (ROS)nonradical Fenton-likepowdered activated carbonregeneration

Identifiers

PMID36399640
PMCPMC9839841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.